Matchpoint Therapeutics
Covalent small molecule therapeutics for immune disease and cancer
- Sector
- Biotech
- Headquarters
- CAMBRIDGE, MA
- Founded
- 2021
- Latest Form D
- $42M, Oct 2022
- Total capital
- $42M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $42M
- 1 Form D · last Oct 2022
- 48 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 9 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$42M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Andre TurenneExecutive Officer, DirectorNamed in SEC Form D filings
- Bruce BoothDirectorNamed in SEC Form D filings
- Daniel BeckerDirectorNamed in SEC Form D filings
- Jason HaflerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 9- PendingPyrrolo-isoquinoline Compounds And Their Use In TherapyUSPTOApplication PCTUS2024054019
- PendingDiazepino-thieno-quinoxaline Compounds And Their Use In TherapyUSPTOApplication PCTUS2024027775
- PendingPyrrolo-isoquinoline Compounds And Their Use In TherapyUSPTOApplication 63595193
Show all 9 patent records
- Pyrrolo-isoquinoline Compounds And Their Use In TherapyApplication PCTUS2024054019Pending
- Diazepino-thieno-quinoxaline Compounds And Their Use In TherapyApplication PCTUS2024027775Pending
- Pyrrolo-isoquinoline Compounds And Their Use In TherapyApplication 63595193Pending
- Diazepino-thieno-quinoxaline Compounds And Their Use In TherapyApplication PCTUS2023072882Pending
- Diazepino-thieno-quinoxaline Compounds And Their Use In TherapyApplication 63463982Pending
- Diazepino-thieno-quinoxaline Compounds And Their Use In TherapyApplication 63463773Pending
- Diazepino-thieno-quinoxaline Compounds And Their Use In TherapyApplication 63435008Pending
- Diazepino-thieno-quinoxaline Compounds And Their Use In TherapyApplication 63401377Pending
- Pyrrolo-isoquinoline Compounds And Their Use In TherapyApplication 19583661Pending
Related companies, and why
- Kinaset TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Korro BioSimilar federal contract value in Biotech · null in contracts
- Altis LabsSimilar federal contract value in Biotech · null in contracts
- Obsidian TherapeuticsSimilar federal contract value in Biotech · null in contracts
- SUNNYLIFE PHARMA INC.Similar federal contract value in Biotech · null in contracts
- Remix TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .